These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19687782)

  • 21. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults.
    Grudell AB; Sweetser S; Camilleri M; Eckert DJ; Vazquez-Roque MI; Carlson PJ; Burton DD; Braddock AE; Clark MM; Graszer KM; Kalsy SA; Zinsmeister AR
    Gastroenterology; 2008 Oct; 135(4):1142-54. PubMed ID: 18725220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF; Wauters MA; De Leeuw IH
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of weight reduction by sibutramine on female sexual function.
    Kim KK; Kang HC; Kim SS; Youn BB
    Int J Obes (Lond); 2006 May; 30(5):758-63. PubMed ID: 16404407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Patients with type III obesity given sibutramine 15 mg/day lose weight in amounts proportional to those in types I and II, but waist circumferences does not decrease proportionally].
    López-Alvarenga JC; Vargas JA; Schneider-Ehrenberg OP; Comuzzie AG; González J; Martínez JL
    Gac Med Mex; 2007; 143(2):109-14. PubMed ID: 17585697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
    Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
    Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
    Bauer C; Fischer A; Keller U
    Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N; Ryan DH; Renz CL; Hewkin AC
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of weight loss on the metabolic syndrome.
    Phelan S; Wadden TA; Berkowitz RI; Sarwer DB; Womble LG; Cato RK; Rothman R
    Int J Obes (Lond); 2007 Sep; 31(9):1442-8. PubMed ID: 17356528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sibutramine, orlistat and Ispaghula in reducing body weight and total body fat content in obese individuals.
    Kazmi SA; Khan M; Mashori GR; Saleem A; Akhtar N; Jahangeer A
    J Ayub Med Coll Abbottabad; 2009; 21(2):45-8. PubMed ID: 20524467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The guanine nucleotide binding protein beta polypeptide 3 gene C825T polymorphism is associated with elite endurance athletes.
    Eynon N; Oliveira J; Meckel Y; Sagiv M; Yamin C; Sagiv M; Amir R; Duarte JA
    Exp Physiol; 2009 Mar; 94(3):344-9. PubMed ID: 19139061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.
    Porter JA; Raebel MA; Conner DA; Lanty FA; Vogel EA; Gay EC; Merenich JA
    Am J Manag Care; 2004 Jun; 10(6):369-76. PubMed ID: 15209480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women.
    Peters WR; MacMurry JP; Walker J; Giese RJ; Comings DE
    Obes Res; 2003 Mar; 11(3):415-9. PubMed ID: 12634439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
    Barratt R; Frost G; O'Boyle A; Millward J; Truby H
    J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of sibutramine in obese type 2 diabetic patients refractory to dietary management.
    Sircar AR; Kumar A; Lal M
    J Assoc Physicians India; 2001 Sep; 49():885-8. PubMed ID: 11837755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sustained weight reduction after cessation of obesity treatment with Sibutramine].
    Wirth A
    Dtsch Med Wochenschr; 2004 Apr; 129(18):1002-5. PubMed ID: 15131746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.
    Kim SH; Lee YM; Jee SH; Nam CM
    Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.
    Daniels SR; Long B; Crow S; Styne D; Sothern M; Vargas-Rodriguez I; Harris L; Walch J; Jasinsky O; Cwik K; Hewkin A; Blakesley V;
    Pediatrics; 2007 Jul; 120(1):e147-57. PubMed ID: 17576783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.